Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits.

@article{Levi1983PreventionAT,
  title={Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits.},
  author={Giulio Levi and Rebeca Tarrab-Hazdai and Vivian Itzhak Teichberg},
  journal={European journal of immunology},
  year={1983},
  volume={13 6},
  pages={500-7}
}
Electrolectin (EL), an endogenous beta-D-galactoside-binding lectin from Electrophorus electricus, was found to have a prophylactic and therapeutic action on the experimental autoimmune myasthenia gravis (EAMG) in rabbits. EAMG is an autoimmune disease induced by immunization with the purified acetylcholine receptor protein (AChR) and is considered to be a… CONTINUE READING